Karl Egerer

Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients

Katharina Hanke, Claudia Brückner, Cornelia Dähnrich et al. · Arthritis Research & Therapy · 2009 · 447 citations · Full text

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure

Stefan D. Anker, Karl Egerer, Hans‐Dieter Volk et al. · The American Journal of Cardiology · 1997 · 393 citations

Inflammation, Cardiomyopathy, Heart Failure +11

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

Holger Bang, Karl Egerer, Anke Gauliard et al. · Arthritis & Rheumatism · 2007 · 291 citations

Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study

J. Detert, H. Bastian, Joachim Listing et al. · Annals of the Rheumatic Diseases · 2012 · 186 citations

Hyperprocalcitonemia in Patients with Noninfectious SIRS and Pulmonary Dysfunction Associated with Cardiopulmonary Bypass 

Mario Hensel, Thomas Volk, W D Döcke et al. · Anesthesiology · 1998 · 126 citations · Full text